Additionally, analysis of cytotoxic T cells indicated that the IFN-γ+ CD4+ T cells and IFN-γ+ CD8+ T cells increased 3.8- and 5.7-fold, respectively, in H22 tumor-bearing mice after treatment with AAGL (Figure 5D). This evidence concerns the gene CD8A and neoplasm.